IL131292A - Pharmaceutical preparations for controlled release of active ingredients - Google Patents
Pharmaceutical preparations for controlled release of active ingredientsInfo
- Publication number
- IL131292A IL131292A IL13129298A IL13129298A IL131292A IL 131292 A IL131292 A IL 131292A IL 13129298 A IL13129298 A IL 13129298A IL 13129298 A IL13129298 A IL 13129298A IL 131292 A IL131292 A IL 131292A
- Authority
- IL
- Israel
- Prior art keywords
- release
- active substance
- matrices
- tablets
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Inorganic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9700225A BE1011045A3 (fr) | 1997-03-14 | 1997-03-14 | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
PCT/BE1998/000033 WO1998041194A1 (fr) | 1997-03-14 | 1998-03-13 | Compositions pharmaceutiques pour la liberation controlee de substances actives |
Publications (2)
Publication Number | Publication Date |
---|---|
IL131292A0 IL131292A0 (en) | 2001-01-28 |
IL131292A true IL131292A (en) | 2004-07-25 |
Family
ID=3890403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13129298A IL131292A (en) | 1997-03-14 | 1998-03-13 | Pharmaceutical preparations for controlled release of active ingredients |
Country Status (20)
Country | Link |
---|---|
US (3) | US6699502B1 (de) |
EP (1) | EP1007005B1 (de) |
JP (1) | JP2001524950A (de) |
KR (1) | KR100500775B1 (de) |
CN (1) | CN1126536C (de) |
AT (1) | ATE275943T1 (de) |
AU (1) | AU736052B2 (de) |
BE (1) | BE1011045A3 (de) |
BR (1) | BR9808239A (de) |
CA (1) | CA2283133C (de) |
DE (1) | DE69826290T2 (de) |
ES (1) | ES2229483T3 (de) |
HK (1) | HK1026152A1 (de) |
ID (1) | ID22980A (de) |
IL (1) | IL131292A (de) |
NZ (1) | NZ337345A (de) |
PL (1) | PL190735B1 (de) |
RO (1) | RO120602B1 (de) |
RU (1) | RU2179017C2 (de) |
WO (1) | WO1998041194A1 (de) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1050306A (ja) * | 1996-07-31 | 1998-02-20 | Toyota Autom Loom Works Ltd | 水素吸蔵合金電極の製造方法 |
BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
US20050085498A1 (en) * | 1998-05-28 | 2005-04-21 | Byrd Edward A. | Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate |
AU6283299A (en) * | 1998-10-01 | 2000-04-17 | Elan Pharma International Limited | Controlled release nanoparticulate compositions |
JP2001107258A (ja) * | 1999-10-06 | 2001-04-17 | Hitachi Ltd | 無電解銅めっき方法とめっき装置および多層配線基板 |
KR101476574B1 (ko) | 1999-10-29 | 2014-12-24 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
EP1118321A1 (de) * | 2000-01-14 | 2001-07-25 | Ucb, S.A. | Feste pharmazeutische Zusammensetzungen für die kontrollierte Freisetzung von aktiven Substanzen |
US6242003B1 (en) | 2000-04-13 | 2001-06-05 | Novartis Ag | Organic compounds |
GB0009522D0 (en) * | 2000-04-19 | 2000-06-07 | Smithkline Beecham Plc | Composition |
BR0115382A (pt) | 2000-10-30 | 2003-09-16 | Euro Celtique Sa | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica |
US20060127474A1 (en) | 2001-04-11 | 2006-06-15 | Oskar Kalb | Pharmaceutical compositions comprising fluvastatin |
IL159287A0 (en) | 2001-06-28 | 2004-06-01 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
CA2451519C (en) * | 2001-06-28 | 2007-11-06 | Ucb, Farchim, S.A. | Tablet comprising cetirizine and pseudoephedrine |
US20030092724A1 (en) * | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
JP2005519053A (ja) * | 2002-01-09 | 2005-06-30 | ユ セ ベ ソシエテ アノニム | 放出が改良された薬剤 |
RU2004129573A (ru) * | 2002-04-04 | 2005-04-10 | Пфайзер Продактс Инк. (Us) | Жевательная таблетка с приятным вкусом |
AU2003272601B2 (en) * | 2002-09-20 | 2009-05-07 | Alpharma Pharmaceuticals, Llc | Sustained-release opioid formulations and methods of use |
US8487002B2 (en) * | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
TWI319713B (en) * | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
WO2004052367A1 (en) * | 2002-12-06 | 2004-06-24 | Ucb Farchim, S.A. | Tablet comprising efletirizine and pseudoephedrine |
US20060172006A1 (en) * | 2003-10-10 | 2006-08-03 | Vincent Lenaerts | Sustained-release tramadol formulations with 24-hour clinical efficacy |
US20060029664A1 (en) * | 2004-08-04 | 2006-02-09 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing carbetapentane and another drug |
US20050281875A1 (en) * | 2003-12-17 | 2005-12-22 | Sovereign Pharmaceuticals, Ltd. | Promethazine containing dosage form |
US9492541B2 (en) * | 2004-09-14 | 2016-11-15 | Sovereign Pharmaceuticals, Llc | Phenylepherine containing dosage form |
US20050232987A1 (en) * | 2004-03-12 | 2005-10-20 | Viswanathan Srinivasan | Dosage form containing a morphine derivative and another drug |
US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
US20050232986A1 (en) * | 2003-12-17 | 2005-10-20 | David Brown | Dosage form containing promethazine and another drug |
US7897172B2 (en) * | 2004-05-18 | 2011-03-01 | L. Perrigo Company | Tablets exhibiting reduced drug release variability |
US9308164B2 (en) * | 2004-06-30 | 2016-04-12 | Sovereign Pharmaceuticals, Llc | Hyoscyamine dosage form |
US9592197B2 (en) * | 2004-12-16 | 2017-03-14 | Sovereign Pharmaceuticals, Llc | Dosage form containing diphenhydramine and another drug |
US20070003622A1 (en) * | 2004-12-16 | 2007-01-04 | Sovereign Pharmaceuticals, Ltd. | Diphenhydramine containing dosage form |
WO2006022996A2 (en) * | 2004-08-04 | 2006-03-02 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
US7529255B2 (en) * | 2005-04-21 | 2009-05-05 | Microsoft Corporation | Peer-to-peer multicasting using multiple transport protocols |
AU2006274263B2 (en) * | 2005-07-26 | 2011-01-27 | Ucb Pharma, S.A. | Pharmaceutical compositions comprising levetiracetam and process for their preparation |
EA014739B1 (ru) | 2005-09-09 | 2011-02-28 | Лабофарм Инк. | Композиция тразодона для введения один раз в день |
US20100172989A1 (en) * | 2006-01-21 | 2010-07-08 | Abbott Laboratories | Abuse resistant melt extruded formulation having reduced alcohol interaction |
US20090022798A1 (en) * | 2007-07-20 | 2009-01-22 | Abbott Gmbh & Co. Kg | Formulations of nonopioid and confined opioid analgesics |
AU2007205866B2 (en) * | 2006-01-21 | 2012-11-29 | Abbott Gmbh & Co. Kg | Dosage form and method for the delivery of drugs of abuse |
US20090317355A1 (en) * | 2006-01-21 | 2009-12-24 | Abbott Gmbh & Co. Kg, | Abuse resistant melt extruded formulation having reduced alcohol interaction |
KR100753480B1 (ko) * | 2006-01-27 | 2007-08-31 | 씨제이 주식회사 | 잘토프로펜 함유 서방성 정제 및 그 제조방법 |
US20070253927A1 (en) * | 2006-04-13 | 2007-11-01 | Gwenaelle Jegou | Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator |
US20100172984A1 (en) * | 2006-06-06 | 2010-07-08 | Bijay Kumar Padhi | tablet dosage form comprising cetirizine and pseudoephedrine |
US20080069891A1 (en) * | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
BRPI0712285A2 (pt) * | 2006-06-19 | 2012-01-10 | Accu Break Technologies Inc | forma de dosagem e método de utilização de uma forma de dosagem |
US8765178B2 (en) | 2006-07-19 | 2014-07-01 | Watson Laboratories, Inc. | Controlled release formulations and associated methods |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
EP2068713B1 (de) | 2006-09-25 | 2012-07-18 | Koninklijke Philips Electronics N.V. | Verschiebung eines objekts für komplette trajektorien in einem rotierenden röntgenbildgebungssystem |
EP2124556B1 (de) | 2006-10-09 | 2014-09-03 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
RU2009123445A (ru) | 2006-11-21 | 2010-12-27 | МакНЕЙЛ-ППС, ИНК. (US) | Анальгетические суспензии модифицированного высвобождения |
US9833510B2 (en) * | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
CA2678092C (en) * | 2007-10-16 | 2013-07-30 | Labopharm Inc. | Bilayer composition for the sustained release of acetaminophen and tramadol |
ES2655477T3 (es) * | 2007-11-21 | 2018-02-20 | The Procter & Gamble Company | Preparaciones útiles para el tratamiento de la tos |
US8486448B2 (en) | 2007-12-17 | 2013-07-16 | Paladin Labs Inc. | Misuse preventative, controlled release formulation |
CA2905541C (en) | 2008-01-09 | 2020-02-11 | Charleston Laboratories, Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
WO2010069050A1 (en) | 2008-12-16 | 2010-06-24 | Labopharm Inc. | Misuse preventative, controlled release formulation |
AU2009332963B2 (en) | 2008-12-31 | 2015-02-05 | Upsher-Smith Laboratories, Llc | Opioid-containing oral pharmaceutical compositions and methods |
EP2451274B1 (de) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
BR112012008317A2 (pt) | 2009-09-17 | 2016-03-22 | Upsher Smith Lab Inc | produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal |
US8927025B2 (en) | 2010-05-11 | 2015-01-06 | Cima Labs Inc. | Alcohol-resistant metoprolol-containing extended-release oral dosage forms |
CN102302497A (zh) * | 2011-05-18 | 2012-01-04 | 天圣制药集团股份有限公司 | 一种治疗过敏性鼻炎的制剂及其制备方法 |
MX361099B (es) | 2013-02-13 | 2018-11-27 | Procter & Gamble | Medicamento con sabor a anís. |
KR102070076B1 (ko) * | 2013-05-03 | 2020-01-29 | 주식회사 제닉 | 탄산 함유 입자를 포함하는 필름 |
WO2015065547A1 (en) | 2013-10-31 | 2015-05-07 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
CA2941829C (en) | 2014-03-11 | 2021-11-02 | Redhill Biopharma Ltd | Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms |
JP2019507181A (ja) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ,インコーポレイテッド | 医薬組成物 |
RU2687715C1 (ru) * | 2018-05-07 | 2019-05-15 | Федеральное государственное бюджетное учреждение науки Институт горного дела Дальневосточного отделения Российской академии наук | Способ комбинированной разработки россыпных месторождений золота |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
US11324707B2 (en) | 2019-05-07 | 2022-05-10 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
KR102073185B1 (ko) * | 2019-07-16 | 2020-02-04 | (주)위바이오트리 | 활성성분을 포함하는 변성 다중층 수산화물 구조체를 포함하는 금속 수산화물 복합체 및 이의 제조 방법 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US477033A (en) * | 1892-06-14 | Bicycle | ||
US4684516A (en) * | 1983-08-01 | 1987-08-04 | Alra Laboratories, Inc. | Sustained release tablets and method of making same |
EP0205336B1 (de) | 1985-06-11 | 1991-09-11 | Teijin Limited | Oral-Arzneizubereitung mit Retardwirkung |
DE3524572A1 (de) * | 1985-07-10 | 1987-01-15 | Thomae Gmbh Dr K | Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung |
US4756911A (en) * | 1986-04-16 | 1988-07-12 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
JPS6396126A (ja) * | 1986-10-13 | 1988-04-27 | Taisho Pharmaceut Co Ltd | 安定化組成物 |
IT1201136B (it) * | 1987-01-13 | 1989-01-27 | Resa Farma | Compressa per uso farmaceutico atta al rilascio in tempi successivi di sostanze attive |
GB8724763D0 (en) * | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
IE60383B1 (en) * | 1988-05-27 | 1994-07-13 | Elan Corp Plc | Controlled release pharmaceutical formulation |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
MX9300110A (es) * | 1992-01-13 | 1994-07-29 | Gerhard Gergely | Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. |
IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
US5411748A (en) * | 1992-10-22 | 1995-05-02 | Song Moon K | Prostate extract supplemented with zinc |
US5314697A (en) * | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
NZ288185A (en) * | 1994-06-15 | 1998-02-26 | Dumex Alpharma As | Particulate pharmaceutical formulation containing coated cores comprising at least 80% of an inert carrier having a friability of <20%; the inert carrier can be calcium carbonate |
EP0811374A1 (de) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin |
CA2277220A1 (en) * | 1997-01-10 | 1998-07-16 | Abbott Laboratories | Tablet for the controlled release of active agents |
BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
-
1997
- 1997-03-14 BE BE9700225A patent/BE1011045A3/fr not_active IP Right Cessation
-
1998
- 1998-03-13 ID IDW991007A patent/ID22980A/id unknown
- 1998-03-13 RU RU99119084/14A patent/RU2179017C2/ru not_active IP Right Cessation
- 1998-03-13 JP JP53995798A patent/JP2001524950A/ja not_active Ceased
- 1998-03-13 AT AT98909235T patent/ATE275943T1/de not_active IP Right Cessation
- 1998-03-13 CA CA002283133A patent/CA2283133C/fr not_active Expired - Fee Related
- 1998-03-13 WO PCT/BE1998/000033 patent/WO1998041194A1/fr active IP Right Grant
- 1998-03-13 RO RO99-00963A patent/RO120602B1/ro unknown
- 1998-03-13 IL IL13129298A patent/IL131292A/en active IP Right Grant
- 1998-03-13 US US09/381,044 patent/US6699502B1/en not_active Expired - Lifetime
- 1998-03-13 DE DE69826290T patent/DE69826290T2/de not_active Expired - Fee Related
- 1998-03-13 CN CN98803222A patent/CN1126536C/zh not_active Expired - Fee Related
- 1998-03-13 PL PL98335832A patent/PL190735B1/pl not_active IP Right Cessation
- 1998-03-13 KR KR10-1999-7008365A patent/KR100500775B1/ko not_active IP Right Cessation
- 1998-03-13 BR BR9808239-6A patent/BR9808239A/pt not_active Application Discontinuation
- 1998-03-13 AU AU63873/98A patent/AU736052B2/en not_active Ceased
- 1998-03-13 ES ES98909235T patent/ES2229483T3/es not_active Expired - Lifetime
- 1998-03-13 NZ NZ337345A patent/NZ337345A/xx unknown
- 1998-03-13 EP EP98909235A patent/EP1007005B1/de not_active Expired - Lifetime
-
2000
- 2000-09-04 HK HK00105542A patent/HK1026152A1/xx not_active IP Right Cessation
-
2002
- 2002-01-28 US US10/055,962 patent/US20020110596A1/en not_active Abandoned
-
2003
- 2003-06-27 US US10/607,047 patent/US7083807B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL131292A0 (en) | 2001-01-28 |
ATE275943T1 (de) | 2004-10-15 |
KR100500775B1 (ko) | 2005-07-12 |
CN1126536C (zh) | 2003-11-05 |
US20040086563A1 (en) | 2004-05-06 |
DE69826290T2 (de) | 2005-02-17 |
HK1026152A1 (en) | 2000-12-08 |
ES2229483T3 (es) | 2005-04-16 |
KR20000076269A (ko) | 2000-12-26 |
CN1250371A (zh) | 2000-04-12 |
DE69826290D1 (de) | 2004-10-21 |
US7083807B2 (en) | 2006-08-01 |
NZ337345A (en) | 2000-04-28 |
JP2001524950A (ja) | 2001-12-04 |
CA2283133C (fr) | 2006-07-25 |
BR9808239A (pt) | 2000-05-16 |
US6699502B1 (en) | 2004-03-02 |
BE1011045A3 (fr) | 1999-04-06 |
AU6387398A (en) | 1998-10-12 |
RU2179017C2 (ru) | 2002-02-10 |
EP1007005B1 (de) | 2004-09-15 |
CA2283133A1 (fr) | 1998-09-24 |
ID22980A (id) | 1999-12-23 |
AU736052B2 (en) | 2001-07-26 |
PL335832A1 (en) | 2000-05-22 |
PL190735B1 (pl) | 2005-12-30 |
US20020110596A1 (en) | 2002-08-15 |
EP1007005A1 (de) | 2000-06-14 |
WO1998041194A1 (fr) | 1998-09-24 |
RO120602B1 (ro) | 2006-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU736052B2 (en) | Pharmaceutical compositions for controlled release of active substances | |
US6861072B1 (en) | Pharmaceutical composition with gastric residence and controlled release | |
EP0833618B1 (de) | Feste oral anzuwendende arzeneiform | |
KR100823392B1 (ko) | 친수성/친유성 중합체 매트릭스 용량적 제제 | |
JP5572616B2 (ja) | 口腔内分散性多層錠剤 | |
US6177102B1 (en) | Once daily analgesic tablet | |
US7569612B1 (en) | Methods of use of fenofibric acid | |
US20100278912A1 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
KR101125268B1 (ko) | 구강 분산성 다중층 정제 | |
JP2004501190A (ja) | 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形 | |
AU2001268722A1 (en) | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition | |
JP2009532331A (ja) | 鎮静剤および睡眠剤の経口放出制御製剤 | |
US20170165228A1 (en) | Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders | |
WO2014071499A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
CZ298851B6 (cs) | Tableta pro rízené podávání úcinných látek | |
US20050244498A1 (en) | Modified-release compositions of at least one form of venlafaxine | |
US20090202633A1 (en) | Extended release formulations of guaifenesin | |
MXPA99008148A (en) | Pharmaceutical compositions for controlled release of active substances | |
SA98190484B1 (ar) | تركيبات دوائية للاطلاق المتحكم فيه لمواد نشطة |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |